Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coffin

Showing results (451-460 of 477) with videos related to

Pageof 48
Sort By:
The Journal of Infectious Diseases|April 22, 2017
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral TherapyCynthia L Gay, Ronald J Bosch, Justin Ritz, et al.
AIDS Research and Human Retroviruses|June 22, 2017
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV InfectionCynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, et al.
Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.
Cancer Science|October 6, 2012
Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptorsNicholas A Mignemi, Doha M Itani, John H Fasig, et al.
Frontiers in Microbiology|October 22, 2019
HIV Infected T Cells Can Proliferate <i>in vivo</i> Without Inducing Expression of the Integrated ProvirusAndrew Musick, Jonathan Spindler, Eli Boritz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapyJ B Dinoso, S Y Kim, A M Wiegand, et al.
Cell Host & Microbe|March 16, 2010
Flexible use of nuclear import pathways by HIV-1KyeongEun Lee, Zandrea Ambrose, Thomas D Martin, et al.
Nature|July 28, 2012
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyN M Archin, A L Liberty, A D Kashuba, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2024
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNAAdam A Capoferri, Ann Wiegand, Feiyu Hong, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNAAdam A Capoferri, Ann Wiegand, Feiyu Hong, et al.
Pageof 48

Showing results (451-460 of 477) with videos related to

Sort By:
Pageof 48
The Journal of Infectious Diseases|April 22, 2017
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral TherapyCynthia L Gay, Ronald J Bosch, Justin Ritz, et al.
AIDS Research and Human Retroviruses|June 22, 2017
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV InfectionCynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, et al.
Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.
Cancer Science|October 6, 2012
Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptorsNicholas A Mignemi, Doha M Itani, John H Fasig, et al.
Frontiers in Microbiology|October 22, 2019
HIV Infected T Cells Can Proliferate <i>in vivo</i> Without Inducing Expression of the Integrated ProvirusAndrew Musick, Jonathan Spindler, Eli Boritz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapyJ B Dinoso, S Y Kim, A M Wiegand, et al.
Cell Host & Microbe|March 16, 2010
Flexible use of nuclear import pathways by HIV-1KyeongEun Lee, Zandrea Ambrose, Thomas D Martin, et al.
Nature|July 28, 2012
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyN M Archin, A L Liberty, A D Kashuba, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2024
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNAAdam A Capoferri, Ann Wiegand, Feiyu Hong, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNAAdam A Capoferri, Ann Wiegand, Feiyu Hong, et al.
Pageof 48